NEOS Surgery S.L. is a certified company of high quality and safety.

TUV logoNeos

Optogenerapy

Optogenerapy-Logo-gris
Optogenerapy
aims at developing and demonstrating a new optogenetics implant for controlled beta interferon (IFN-ß) protein delivery for treating patients suffering from multiple sclerosis. The new implant will be the result of the cooperation of 11 European partners, including Universities, Tech centres, Health institutions, SMEs and big companies.

NEOS is contributing in the project by developing the instruments required for the optimal implantation of the new device.

Find more details at Optogenerapy's website.

EU-emblem This project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 720694.

 

Parque Tecnológico del Vallés, c/Ceramistes 2. 08290 Cerdanyola del Vallès (Barcelona) telf. 93 594 47 26

Parque Tecnológico Miramon, Paseo Mikeletegui 2. 20009 Donostia - San Sebastián (Guipúzcoa) telf. 94 300 09 17

NEOS Surgery, S.L. 2009 - Some rights reserved - Working under Joomla - Web designed by DDM Visual

info@neosurgery.com